Human trials for nasal spray vaccines scheduled for end of 2021
Government officials announced today that 2 Covid vaccines that are delivered via a nasal spray and are homegrown in Thailand are going to start human trials… by the end of 2021. Officials say the vaccines already had promising results using mice.
The nasal spray was developed by the National Center for Genetic Engineering and Biotechnology. Government spokesperson Ratchada Thanadirek says the vaccines are based on the adenovirus and influenza.
Post-mice trials, the first human trials should start sometime at the end of this year. However, the vaccines still need the FDA’s approval. The trials are also intended to test their protection against the Delta variant. The second phase, which should begin next March has a target date set for wider release in “Mid 2022″…If the results are “good”, says Ratchada.
Previously, Thailand’s FDA had warned the public that “spray guns” are dangerous and ineffective.
Meanwhile, Thailand is also developing an mRNA vaccine through Chulalongkorn University and an inactivated virus is being developed by Mahidol University. Both vaccines should start the second phase of human trials this month.
2 days prior, Chulalongkorn closed its vaccine trial applications after enough people signed up.
Thailand has fully vaccinated just under 7% of its residents.
SOURCE: Bangkok Post
Join the conversation and have your say on Thailand news published on The Thaiger.
Thaiger Talk is our new Thaiger Community where you can join the discussion on everything happening in Thailand right now.
Please note that articles are not posted to the forum instantly and can take up to 20 min before being visible. Click for more information and the Thaiger Talk Guidelines.
Recent comments: